BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Al-Qahtani AA, Al-Anazi MR, Nazir N, Ghai R, Abdo AA, Sanai FM, Al-Hamoudi WK, Alswat KA, Al-Ashgar HI, Khan MQ, Albenmousa A, Cruz DD, Bohol MFF, Al-Ahdal MN. Hepatitis B virus (HBV) X gene mutations and their association with liver disease progression in HBV-infected patients. Oncotarget 2017;8:105115-25. [PMID: 29285238 DOI: 10.18632/oncotarget.22428] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Al-Sadeq DW, Taleb SA, Zaied RE, Fahad SM, Smatti MK, Rizeq BR, Al Thani AA, Yassine HM, Nasrallah GK. Hepatitis B Virus Molecular Epidemiology, Host-Virus Interaction, Coinfection, and Laboratory Diagnosis in the MENA Region: An Update. Pathogens 2019;8:E63. [PMID: 31083509 DOI: 10.3390/pathogens8020063] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
2 Cortese MF, González C, Gregori J, Casillas R, Carioti L, Guerrero-Murillo M, Riveiro-Barciela M, Godoy C, Sopena S, Yll M, Quer J, Rando A, Lopez-Martinez R, Pacín Ruiz B, García-García S, Esteban-Mur R, Tabernero D, Buti M, Rodríguez-Frías F. Sophisticated viral quasispecies with a genotype-related pattern of mutations in the hepatitis B X gene of HBeAg-ve chronically infected patients. Sci Rep 2021;11:4215. [PMID: 33603102 DOI: 10.1038/s41598-021-83762-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Panasiuk YV, Vlasenko NV, Churilova NS, Klushkina VV, Dubodelov DV, Kudryavtseva EN, Korabelnikova MI, Rodionova ZS, Semenenko TA, Kuzin SN, Akimkin VG. [Modern views on the role of X gene of the hepatitis B virus (Hepadnaviridae: Orthohepadnavirus: Hepatitis B virus) in the pathogenesis of the infection it causes]. Vopr Virusol 2022;67:7-17. [PMID: 35293184 DOI: 10.36233/0507-4088-84] [Reference Citation Analysis]
4 Salpini R, Surdo M, Cortese MF, Palumbo GA, Carioti L, Cappiello G, Spanò A, Trimoulet P, Fleury H, Vecchiet J, Pasquazzi C, Mirabelli C, Scutari R, Sacco A, Alkhatib M, Missale G, Francioso S, Sarmati L, Andreoni M, Angelico M, Ceccherini-Silberstein F, Levrero M, Perno CF, Belloni L, Svicher V. The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro. Clin Microbiol Infect 2019;25:906.e1-7. [PMID: 30472417 DOI: 10.1016/j.cmi.2018.11.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
5 Zhu RX, Yang DY, Seto WK. Impact of wild-type and carboxyl-terminal truncated hepatitis B virus X on hepatocyte proliferation. Shijie Huaren Xiaohua Zazhi 2018; 26(13): 760-768 [DOI: 10.11569/wcjd.v26.i13.760] [Reference Citation Analysis]
6 Hayashi S, Nagaoka K, Tanaka Y. Blood-Based Biomarkers in Hepatitis B Virus-Related Hepatocellular Carcinoma, Including the Viral Genome and Glycosylated Proteins. Int J Mol Sci 2021;22:11051. [PMID: 34681709 DOI: 10.3390/ijms222011051] [Reference Citation Analysis]
7 Jiang X, Chang L, Yan Y, Wang L. Paradoxical HBsAg and anti-HBs coexistence among Chronic HBV Infections: Causes and Consequences. Int J Biol Sci 2021;17:1125-37. [PMID: 33867835 DOI: 10.7150/ijbs.55724] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Mani M, Vijayaraghavan S, Sarangan G, Barani R, Abraham P, Srikanth P. Hepatitis B virus X protein: The X factor in chronic hepatitis B virus disease progression. Indian J Med Microbiol 2019;37:387-92. [PMID: 32003338 DOI: 10.4103/ijmm.IJMM_19_421] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Lin CL, Chu YD, Yeh CT. Emergence of Oncogenic-Enhancing Hepatitis B Virus X Gene Mutants in Patients Receiving Suboptimal Entecavir Treatment. Hepatology 2019;69:2292-6. [PMID: 30552766 DOI: 10.1002/hep.30423] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
10 Madihi S, Syed H, Lazar F, Zyad A, Benani A. A Systematic Review of the Current Hepatitis B Viral Infection and Hepatocellular Carcinoma Situation in Mediterranean Countries. Biomed Res Int 2020;2020:7027169. [PMID: 32626758 DOI: 10.1155/2020/7027169] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
11 Shivlata L, Pacholi S, Chouksey VK, Barde PV. Molecular characterization of hepatitis B virus reveals circulation of multiple subgenotypes of genotype D with clinically important mutations in central India. Indian J Med Microbiol 2021;39:67-72. [PMID: 33515632 DOI: 10.1016/j.ijmmb.2021.01.002] [Reference Citation Analysis]
12 Wungu CDK, Amin M, Ruslan SEN, Purwono PB, Kholili U, Maimunah U, Setiawan PB, Lusida MI, Soetjipto S, Handajani R. Association between host TNF-α, TGF-β1, p53 polymorphisms, HBV X gene mutation, HBV viral load and the progression of HBV-associated chronic liver disease in Indonesian patients. Biomed Rep 2019;11:145-53. [PMID: 31565220 DOI: 10.3892/br.2019.1239] [Reference Citation Analysis]
13 Javanmard D, Karbalaie Niya MH, Khalafkhany D, Najafi M, Ziaee M, Babaei MR, Kiani SJ, Esghaei M, Jazayeri SM, Panahi M, Safarnezhad Tameshkel F, Mehrabi M, Monavari SH, Bokharaei-salim F. Downregulation of GSK3β and Upregulation of URG7 in Hepatitis B-Related Hepatocellular Carcinoma. Hepat Mon 2020;20. [DOI: 10.5812/hepatmon.100899] [Reference Citation Analysis]